NSAIDs Have Protective Effects On Alzheimer Disease
Results of a study show that long-term nonsteroidal anti-inflammatory drug (NSAID) use was protective against Alzheimer disease.
|
Alzheimer's Risk Factors Vary For Genders
Factors increasing risk for developing Alzheimer's disease are different for men and women.
|
Black, Hispanic Caregivers More Likely To Misinterpret Signs Of Alzheimer's
Hispanic and black caregivers are more likely than other ethnic groups to misinterpret symptoms of Alzheimer's disease as normal signs of aging.
|
Medivation's Dimebon Improved Thinking, Memory In Alzheimer's Patients
Alzheimer's patients treated with Medivation's investigational drug Dimebon showed improvement in the key aspects of cognitive function over a one-year period compared with placebo.
|
Dimebon Significantly Improved Daily Function In Alzheimer's Patients
Alzheimer's patients taking the investigational drug Dimebon showed significant improvement in their ability to perform daily tasks over a one-year period compared to placebo.
|
Gammagard May Target Primary Pathway Involved In Alzheimer's Disease
A study demonstrates natural antibodies contained in GAMMAGARD LIQUID, a plasma-derived antibody replacement therapy indicated for primary immunodeficiency disorders and being studied in Alzheimer's disease, binds directly to multiple aggregated, or clustered, forms of the beta-amyloid peptide molecule.
|
Drinking, Smoking, Cholesterol Increase Alzheimer's Risk
High cholesterol and bad habits like drinking alcohol and smoking cigarettes speeds the start Alzheimer's disease.
|
rBChE May Play A Neuroprotective Role In Alzheimer's Disease
Scientists have recently obtained new data suggesting that recombinant butyrylcholinesterase (rBChE), a non-pegylated form of Protexia, may have neuroprotective benefits.
|
Alzheimer's Patients Do Not Benefit From Antipsychotic Drugs
Alzheimer's patients don't show significant improvement of cognitive decline and neuropsychiatric problems when taking antipsychotic drugs.
|
Lilly Launches Trial For Treatment Of Alzheimer's Disease
Eli Lilly and Company starts a Phase III clinical trial studying LY450139, an investigational gamma secretase inhibitor for the treatment of mild to moderate Alzheimer's disease.
|
New Treatment Test For Alzheimer's Disease From Lilly
Eli Lilly and Company has announced today the start of a Phase III clinical trial studying LY450139, an investigational gamma secretase inhibitor for the treatment of mild to moderate Alzheimer's disease.
|
Gamma Secretase Modulators Promising In Alzheimer's Animal Model Studies
Gamma secretase modulators have shown promise in Alzheimer's disease animal model efficacy studies.
|
Children Help Care For Loved Ones With Alzheimer's Disease
Results from the third annual AFA ICAN: Investigating Caregivers' Attitudes and Needs Survey suggest that Alzheimer's disease care is a family affair.
|
Medivation's Dimebon Stabilizes Behavioral Symptoms In Alzheimer's Patients
Clinical results from a trial showed that behavioral symptoms were stabilized in patients with mild-to-moderate Alzheimer's disease over a one-year period.
|
Baby Boomers Face Alzheimer's Disease
By 2050 researchers expect the number of Alzheimer's patients to be about 10 million.
|
Researchers Use Light To Detect Alzheimer's
Researchers have developed a way of examining brain tissue with near-infrared light to detect signs of Alzheimer's disease.
|
Alzheimer's finding may shed new light on memory loss
Researchers believe that normal memory loss is hyper-activated in Alzheimer's disease (AD) and that this effect is key to the profound memory loss associated with the incurable neurodegenerative disorder.
|
Imaging Study Reveals Rapid Formation Of Alzheimer's-Associated Plaques
The amyloid plaques found in the brains of Alzheimer's disease patients may form much more rapidly than previously expected.
|
Alzheimer's Molecule Is A Smart Speed Bump
Proteins carrying chemical cargo in nerve cells react differently when exposed to the tau protein, which plays an important role in Alzheimer's disease.
|
Report Tackles Changing Landscape For Alzheimer's Diagnostics
Alzheimer's Disease publication designed to provide critical strategic insight for pharma and biotech companies with as take in the market for diagnostics and treatments in this disease area.
|
Innovative Brain Scanning For Alzheimer's Unveiled
Researchers are launching an Alzheimer's screening clinical trial with Neuronetrix's innovative brain scanning system, called COGNISION.
|
Study Demonstrates New Role For DHA In Alzheimer's Disease
In a recent pre-clinical study an omega-3 fatty acid found in algae called docosahexaenoic acid, or DHA, was found to decrease an important risk factor for late-onset Alzheimer's disease.
|
Experts Challenge Existence Of Alzheimer's As Disease
Case Western Reserve University School of Medicine professor of neurology challenges conventional wisdom and assumptions of brain aging in new book 'The Myth of Alzheimer's'.
|
Researchers Study Genes Associated With Late Onset Alzheimer's Disease
New study to create a large bank of genetic material, cell lines, and data from families with multiple members with late-onset Alzheimer's disease.
|
Fish oil has anti-Alzheimer's mechanism
UCLA researchers find anti-Alzheimer's mechanism in omega-3 fatty acids.
|
Researchers Examine Alzheimer's, Parkinson's Disease
The TI Pharma project is a large-scale study into the brain material of Alzheimer's and Parkinson's patients, who gave permission to the Netherlands Brain Bank for their tissue to be used for scientific research.
|
Anavex Advances Drug Candidate For Treatment Of Alzheimer's Disease
Anavex Life Sciences announces promising developments with ANAVEX 1-41, the company's lead drug candidate for Alzheimer's disease.
|
High Blood Pressure May Heighten Effects Of Alzheimer's Disease
Having hypertension, or high blood pressure, reduces blood flow in the brains of adults with Alzheimer's disease.
|
Novartis's Exelon Patch For Treatment Of Alzheimer's Disease Not Yet Widely Used
Novartis's Exelon patch, applied once daily for the treatment of mild to moderate Alzheimer's disease, is not yet widely used by primary care physicians.
|
Latinos, African Americans Live Longer With Alzheimer's Disease
Latinos and African Americans with Alzheimer's disease live longer than white people who have the disease.
|
November Is Alzheimer's Disease Awareness Month
There are more than 5 million Americans suffering from Alzheimer's disease, and an estimated 11 to 16 million will have Alzheimer's by the year 2050.
|
Black, Hispanic Alzheimer's Patients Live Longer
Black and Hispanic Alzheimer's patients live longer than whites, Asian-Americans and American Indians who have the disease.
|
High Blood Pressure, Chest Pains Speed Up Progression Of Alzheimer's Disease
People with Alzheimer's disease who have high blood pressure, chest pains or an irregular heartbeat may lose their memories faster than others with Alzheimer's disease.
|
Eating Grapes May Protect Against Alzheimer's Disease
Consuming grapes may help prevent the onset of Alzheimer's disease.
|
November Is National Alzheimer's Disease Awareness Month
Los Angeles Jewish Home is marking November's National Alzheimer's Disease Awareness Month by calling for increased understanding of an illness.
|
Pet Scan Distinguishes Alzheimer's From Other Dementia
A PET scan (positron emission tomography) that measures uptake of sugar in the brain significantly improves the accuracy of diagnosing a type of dementia often mistaken for Alzheimer's disease.
|
Brain Marker Shows Promise For Predicting Future Alzheimer's Disease
Researchers have used imaging technology to identify a new marker that may help identify those at greatest risk for cognitive decline and the development of Alzheimer's disease.
|
Scientists Use Shared Genome Data To Confirm Gene Linked To Alzheimer's
Until recently, only one of the approximately 30,000 genes in the human genome has been linked to risk of late-onset Alzheimer's disease (AD).
|
Dementia prevalent in 1 or 7 Americans
About 2.4 million of those with dementia, or 9.7 percent of the population age 71 and older, were found to have Alzheimer's disease, the most common cause of dementia, according to the study.
|
Alzheimer's Disease Treatment Possible With Blood Pressure Drug
Alzheimer's disease treatment with certain antihypertensive agents might be of benefit to individuals with, or at high risk of developing, Alzheimer's disease.
|
